iRhythm Technologies Inc (IRTC)
88.21
+0.08
(+0.09%)
USD |
NASDAQ |
May 31, 16:00
87.98
-0.23
(-0.26%)
After-Hours: 20:00
iRhythm Technologies Research and Development Expense (Annual): 60.24M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 60.24M |
| December 31, 2022 | 46.61M |
| December 31, 2021 | 38.67M |
| December 31, 2020 | 41.33M |
| December 31, 2019 | 37.30M |
| Date | Value |
|---|---|
| December 31, 2018 | 20.86M |
| December 31, 2017 | 13.26M |
| December 31, 2016 | 7.15M |
| December 31, 2015 | 6.349M |
| December 31, 2014 | 5.698M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
37.30M
Minimum
2019
60.24M
Maximum
2023
44.83M
Average
41.33M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.741B |
| Alphatec Holdings Inc | 70.12M |
| AtriCure Inc | 73.92M |
| Intuitive Surgical Inc | 998.80M |
| RxSight Inc | 29.05M |